Endovascular treatment of malignant superior vena cava syndrome secondary to lung cancer.
Laura Calsina JuscafresaIgnacio Gil BazoLukasz GrochowiczMaría Páramo AlfaroJosé María López-Picazo GonzálezMarta Moreno JiménezJose Ignacio Bilbao JaureguizarPublished in: Hospital practice (1995) (2017)
Stent placement in malignant SVCS seems to be an effective and rapid treatment for the relief of symptoms and quality of life improvement with a relatively low complications rate with a rapid resolution of symptoms. Therefore, it should be seriously considered as the first option in the SVC obstruction treatment.